XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity and Stock-Based Compensation (Tables)
3 Months Ended
Apr. 02, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation Expenses

The following table shows stock-based compensation expense included in the condensed consolidated statements of operations for the three months ended April 2, 2022 and April 3, 2021:

 

 

 

Three Months Ended

 

(in thousands)

 

April 2, 2022

 

 

April 3, 2021

 

Cost of revenues

 

$

60

 

 

$

47

 

Research and development

 

 

29

 

 

 

36

 

Sales and marketing

 

 

122

 

 

 

98

 

General and administrative

 

 

173

 

 

 

185

 

 

 

$

384

 

 

$

366

 

Summary of Stock Options

The following table summarizes stock options information during the three months ended April 2, 2022:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

Per Share

 

 

Aggregate

Intrinsic

Value

(thousands)

 

Outstanding as of January 1, 2022

 

 

1,772,621

 

 

$

5.07

 

 

 

 

 

Granted

 

 

42,200

 

 

 

4.73

 

 

 

 

 

Exercised

 

 

(6,063

)

 

 

2.25

 

 

 

 

 

Canceled or forfeited

 

 

(66,841

)

 

 

9.41

 

 

 

 

 

Outstanding as of April 2, 2022

 

 

1,741,917

 

 

$

4.91

 

 

$

1,204

 

Weighted Average Assumptions for Fair Value Estimate of Stock-Based Awards (Options)

The Company uses the Black-Scholes option-pricing model to estimate the fair value of stock-based awards (options) with the following weighted average assumptions:

 

 

 

Three Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

Average risk free interest rate

 

 

2.43

%

 

 

0.74

%

Expected life (in years)

 

4.5

 

 

4.45

 

Dividend yield

 

 

%

 

 

%

Average volatility

 

 

76

%

 

 

72

%

Summary of Stock Options Outstanding, Vested, Expected to Vest and Exercisable

Information regarding stock options outstanding, vested, expected to vest, and exercisable as of April 2, 2022 is summarized below:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

 

Aggregate

Intrinsic Value

(thousands)

 

Options outstanding

 

 

1,741,917

 

 

$

4.91

 

 

 

5.45

 

 

$

1,204

 

Options vested and expected to vest

 

 

1,637,953

 

 

$

4.90

 

 

 

5.39

 

 

$

1,157

 

Options exercisable

 

 

662,311

 

 

$

5.30

 

 

 

4.41

 

 

$

414

 

Restricted Stock Units

Information regarding RSUs activity for the three months ended April 2, 2022 is summarized below:

 

 

 

Number

of Shares

 

Outstanding as of January 1, 2022

 

 

253,761

 

RSUs granted

 

 

 

RSUs released

 

 

(4,937

)

RSUs forfeited

 

 

 

Outstanding as of April 2, 2022

 

 

248,824